FASEB J. Avanti Polar Lipids
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.08-127928.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Buy
Right arrow All Versions of this Article:
fj.08-127928v1
23/9/3129    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Ortiz-Muñoz, G.
Right arrow Articles by Meilhac, O.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ortiz-Muñoz, G.
Right arrow Articles by Meilhac, O.
(The FASEB Journal. 2009;23:3129-3139.)
© 2009 FASEB

HDL antielastase activity prevents smooth muscle cell anoikis, a potential new antiatherogenic property

Guadalupe Ortiz-Muñoz*,{dagger},{ddagger}, Xavier Houard*,{dagger},{ddagger}, Jose-Luis Martín-Ventura*,{dagger},{ddagger}, Brian Y. Ishida§, Stéphane Loyau*,{dagger},{ddagger}, Patrick Rossignol,||,#,**,{dagger}{dagger},{ddagger}{ddagger}, Juan-Antonio Moreno*,{dagger},{ddagger}, John P. Kane§, Robert J. Chalkley§, Alma L. Burlingame§, Jean-Baptiste Michel*,{dagger},{ddagger} and Olivier Meilhac*,{dagger},{ddagger}

* INSERM, U698, Paris, France;

{dagger} University of Paris 7, Paris, France;

{ddagger} Centre Hospitalier Universitaire X. Bichat, Paris, France;

§ University of California, San Francisco, San Francisco, California, USA;

Centre Hospitalier Universitaire de Nancy, Hôpital Jeanne d’Arc, Dommartin-lès-Toul, France;

|| INSERM, Centre d’Investigation Clinique de Nancy CIC-P 9501, Dommartin-lès-Toul, France;

# Faculté de Médecine, Nancy-Université, Vandoeuvre-les-Nancy, France;

** INSERM, U961, Vandoeuvre-les-Nancy, France;

{dagger}{dagger} Service de Médecine Vasculaire et Hypertension artérielle and Centre d’Investigation Clinique, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris, France; and

{ddagger}{ddagger} Faculté de Médecine René Descartes Paris 5, Paris, France

1 Correspondence: INSERM U698, Hôpital X. Bichat, 46, rue Henri Huchard, 75877 Paris cedex 18, France. E-mail: olivier.meilhac{at}inserm.fr

Various studies using proteomic approaches have shown that HDL can carry many proteins other than its constitutive apolipoprotein A-I (apoA-I). Using mass spectrometry and Western blotting, we showed the presence of {alpha}1-antitrypsin (AAT) (SERPINA1, serpin peptidase inhibitor, clade A, an elastase inhibitor) in HDL, isolated either by ultracentrifugation or by selected-affinity immunosorption using an anti-apoA-I column. Furthermore, we report that HDL possesses potent antielastase activity. We further showed that only HDL but not LDL is able to bind AAT. HDL-associated AAT was able to inhibit extracellular matrix degradation, cell detachment, and apoptosis induced by elastase in human vascular smooth muscle cells (VSMCs) and in mammary artery cultured ex vivo. Degradation of fibronectin by elastase used as a marker of pericellular proteolysis was prevented by addition of HDL. Elastase present in aortic abdominal aneurysm (AAA) thrombus samples was also able to induce apoptosis of VSMCs in culture. This phenomenon was prevented by addition of HDL but not of LDL. Finally, we report that the proportion of AAT in HDL isolated from patients with an AAA is decreased relative to that from matched control subjects, suggesting a reduced capacity of HDL to inhibit elastase in these patients. In conclusion, our data provide evidence of a new potential antiatherogenic property of HDL attributable to AAT and its antielastase activity.—Ortiz-Muñoz, G., Houard, X., Martín-Ventura, J.-L., Ishida, B. Y., Loyau, S., Rossignol, P., Moreno, J.-A., Kane, J. P., Chalkley, R. J., Burlingame, A. L., Michel, J.-B., Meilhac, O. High-density lipoprotein antielastase activity prevents smooth muscle cell anoikis, a potential new antiatherogenic property.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by The Federation of American Societies for Experimental Biology.